{"id":"W2949614109","doi":"10.1002/hon.106_2630","title":"PHASE 1B KEYNOTE‐013 STUDY OF PEMBROLIZUMAB IN PATIENTS WITH CLASSIC HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE: RESULTS OF >4 YEARS OF FOLLOW‐UP","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Pembrolizumab; Autologous stem-cell transplantation; Oncology; Cohort; Population; Lymphoma; Progression-free survival; Surgery; Chemotherapy; Hodgkin lymphoma; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002532888,0.0009544457,0.001118037,0.0002478212,0.0004395952,0.0007523416,0.0005232004,0.0007482505,0.002088792],"category_scores_gemma":[0.0008845414,0.0004148429,0.001017007,0.0003830595,0.0004996765,0.0008706503,0.000451814,0.001691401,0.0006694876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008108972,"about_ca_system_score_gemma":0.0008251648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007222318,"about_ca_topic_score_gemma":0.001237884,"domain_scores_codex":[0.9995273,0.0002142478,0.00003082719,0.0000857729,0.00005298303,0.00008879446],"domain_scores_gemma":[0.9992297,0.0001076502,0.000229409,0.00008491648,0.00008033415,0.0002680429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7100242,0.02779897,0.1185416,0.0008462424,0.004483241,0.0004819248,0.0004468942,0.002932975,0.02113072,0.0002108522,0.007471073,0.1056314],"study_design_scores_gemma":[0.3615226,0.3715971,0.2489891,0.00009108552,0.002376682,0.0009310755,0.0001599087,0.001840425,0.004565306,0.0003341558,0.007527316,0.00006535989],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931709,0.002000183,0.0003841429,0.0002220282,0.00004180605,0.0009662945,0.002072793,0.00004254701,0.001099472],"genre_scores_gemma":[0.9914011,0.0007764046,0.0006084035,0.0005281739,0.00007468656,0.0009736011,0.004122474,0.00001495184,0.001500072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002532888,"threshold_uncertainty_score":0.01339531,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01381244760435406,"score_gpt":0.2820307867718148,"score_spread":0.2682183391674607,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}